Together these data indicate that although vagal afferent neurons may contribute to hypophagia induced by peripheral administration of GLP-1R analogs, these neurons are not necessary for the hypophagic effect
The demographic breakdown shows GLP-1 adoption across income levels, though wealthier populations initially had greater access due to high out-of-pocket costs through traditional pharmacy channels
Surging demand for GLP-1 drugs has outstripped production capacity, leading to shortages and supply delays
[68] [69] In November 2025, the Trump Administration announced TrumpRx to lower the price of GLP-1 drugs to $245 per month for people covered by Medicare
Background on Obesity and Its Mechanisms The prevalence of obesity is a major public health concern, because of the associated weight-related diseases that result in significant morbidity and mortality and reduced quality of life
Besides guidance on screening and prevention, OPM specified that carriers must cover at least one GLP-1 weight-loss drug